🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are excited to announce the launch of our newly designed website! Our new site provides you with greater access to who we are, the markets we serve and our competitive differentiation. Check it out now: ixlayer.com

See you in a couple days at #HLTH2023? Find out why ixlayer’s cloud-based platform is an industry leader for diagnostic health testing. Stop by our booth 3427 or schedule a meeting today: ixlayer.com/hlth-2023/

We’re excited to announce the launch of our new data visualization solution that empowers healthcare organizations to harness real-time data for actionable insights to improve outcomes across the healthcare ecosystem. Read more: bit.ly/3PLNfYV

We’re pleased to announce the expansion to our Clinical Advisory Board with the addition of Kevin Ban, MD, Chief Medical Officer with Walgreens. Dr Ban brings over 25 years of clinical and administrative experience. Read more: bit.ly/3ZWkU6E

🎉We are thrilled to announce ixlayer as a proud partner for #DPEAST 2024! Get tickets to Digital Pharma East here: ow.ly/CJVx50QhxEt #DigitalPharma #DigPharm #pharmamarketing #digitalmarketing #marketing #innovationinhealthcare

New ixlayer survey shows a large support of at-home diagnostic testing: hubs.li/Q02DdY_f0

Doctors support growth of at-home testing, survey finds, opening new avenues for biopharma patient outreach fiercepharma.com/marketing/doct…

HCPs show cautious support for at-home diagnostic testing mmm-online.com/home/channel/h…

NEW IXLAYER PHYSICIAN SURVEY REVEALS OVERWHELMING SUPPORT FOR AT-HOME DIAGNOSTIC TESTING: prnewswire.com/news-releases/…

ixlayer direct-to-patient platform allows biopharma organizations to quickly launch an optimized patient Cx with transparency and control. Our configurable platform enables us to build distinct programs for multiple therapeutic areas within biopharma ecosystem.

Attending #DPE24? Don’t miss out on our panel discussion, “Leveraging Technology to Improve the Patient Experience and Drive Better Outcomes” featuring insights marketers from Sanofi , AstraZeneca, CSL Behring. #DigitalPharmaEast #FiercePharma #DigitalPharma #PharmaMarketing

We’re pleased to announce the launch of ixEngage, our direct-to-patient solution for biopharma that builds on our groundbreaking digital platform that has powered 1,110+ nationwide programs and over 4 million patient care journeys: prnewswire.com/news-releases/…

Today at #HLTHUSA, we announced the availability of a Complete Blood Count (CBC) test with at-home sample collection for direct-to-patient (DTP) biopharma programs. Routine CBC tests is used for asthma, heart disease, and kidney disease. #HLTHUSA2024 #hlth ixlayer.com/complete-blood…

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients. Congratulations! #HLTHUSA

We're so proud to share that ixlayer has announced their Complete Blood Count test with their direct-to-patient biopharma programs through ixEngage. ixLayer is paving the future for at-home testing access for patients. Congratulations! #HLTHUSA

Proud to powering Screening Central,Sanofi US first #telehealth-enabled, user-initiated #T1D autoantibody screening platform, now available across the U.S. Expanding access to early screening means more #proactivehealth and better #healthoutcomes. sanofi.us/en/sanofi-toda…

We are excited to be named to the Digital Health New York 100, joining the ranks of past winners Capsule Health , Maven Clinic , Oscar, Ro , Sword Health , Talkiatry , talkspace and Zocdoc. Read more in today's press release: ixlayer.com/2025/02/06/ixl…

Almost every pharma marketer and commercialization leader is asking about direct-to-patient platform opportunities. But what do patients want? Thanks to FiercePharma and the reporting by Andrea Park on the ixlayer #ixInsight2025 Study with Ipsos. fiercepharma.com/marketing/phar…

L.A. Care is a finalist in the FierceHealthcare #DEIAwards for Outstanding DEI Initiative in Patient Care with our partner ixlayer! Our At-Home Diagnostic Program nearly doubled our preventive colorectal cancer, diabetes, and kidney disease screenings rates.📦🩺